| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |